CORPORATE INFO FOR INVESTORS OUR PRODUCTS BUSINESS DEVELOPMENT CONTACT US HOME

Menu

Financial Statements
  • Financial Reports
  • Securities Filing
      
    Investor Resources
  • Fact Sheet
  • Presentations
  • Analyst Coverage
  • Calendar of Events
  • FAQ
  • Shareholder
         Services
  • Investor Kit
  • Investor Information

    News
  • Press Releases
  • Corporate News
  • Awards
    •   PRESS RELEASES  
    COMMUNIQUÉS DE PRESSE (Français)

    2013  |  2012  |  2011  |  2010  |  2009  |  2008  |  2007  |    2006  |   2005  |   2004  |   2003  |   2002  |   2001  |   2000  |   1999  |   1998  |   1997  |  


    December 22, 2006
    PALADIN LICENSES PENNSAID 'R' PLUS RIGHTS FROM NUVO
    (Also in PDF format)
    December 18, 2006
    PALADIN SHARES NOW QUALIFY FOR QUEBEC SME GROWTH STOCK PLAN
    (Also in PDF format)
    December 12, 2006
    PALADIN AND AUXILIUM SIGN EXCLUSIVE DISTRIBUTION AGREEMENT FOR TESTIM'R'
    December 1, 2006
    PALADIN TO ASSUME PENNSAID'R' PROMOTION
    (Also in PDF format)
    November 10, 2006
    PALADIN LABS EXPANDS PRESENCE INTO GROWING PAIN MARKET
    (Also in PDF format)
    November 2, 2006
    PALADIN REPORTS RECORD REVENUES FOR THIRD QUARTER & INCREASES REVENUE GUIDANCE
    (Also in PDF format)
    November 1, 2006
    PALADIN TO PRESENT AT CIBC WORLD MARKETS HEALTHCARE CONFERENCE IN NEW YORK
    (Also in PDF format)
    October 26, 2006
    NOTICE OF PALADIN LAB'S THIRD QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    September 29, 2006
    PALADIN TO PRESENT AT CIBC WORLD MARKETS INSTITUTIONAL INVESTOR CONFERENCE IN MONTREAL
    September 28, 2006
    PALADIN TO PRESENT AT BIOCONTACT CONFERENCE IN QUEBEC CITY
    (Also in PDF format)
    August 31, 2006
    PALADIN TO PRESENT AT ROTH CAPITAL 2006 CONFERENCE
    (Also in PDF format)
    August 3, 2006
    PALADIN REPORTS RECORD SECOND QUARTER RESULTS AND PROVIDES UPWARD REVENUE GUIDANCE FOR 2006
    (Also in PDF format)
    July 27, 2006
    NOTICE OF PALADIN LAB'S SECOND QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    May 26, 2006
    PALADIN LABS INC.: HEALTH CANADA REQUIRES ADDITIONAL INFORMATION FOR GLUCAGEN'R' APPROVAL
    (Also in PDF format)
    May 11, 2006
    PALADIN REPORTS 2006 FIRST QUARTER FINANCIAL RESULTS
    (Also in PDF format)
    May 4, 2006
    NOTICE OF PALADIN LAB'S FIRST QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    April 27, 2006
    PALADIN TO PRESENT AT UPCOMING BIOFINANCE 2006 CONFERENCE IN TORONTO
    (Also in PDF format)
    April 26, 2006
    GENEROUS DONATION TO HPIC IS MADE ON BEHALF OF PALADIN IN SUPPORT OF HUMANITARIAN AID IN NICARAGUA
    (Also in PDF format)
    April 24, 2006
    PALADIN WINS MERCURIADES AWARD FOR BEST COMPANY IN TRADE AND DISTRIBUTION
    April 18, 2006
    PALADIN TO PRESENT AT UPCOMING UBS GLOBAL SPECIALTY PHARMACEUTICALS CONFERENCE IN NEW YORK
    (Also in PDF format)
    March 29, 2006
    PALADIN TO PRESENT AT UPCOMING CIBC BIOTECHNOLOGY AND SPECIALTY PHARMACEUTICALS CONFERENCE IN NEW YORK
    March 14, 2006
    HEALTH CANADA APPROVES VANTAS'R' FOR THE TREATMENT OF ADVANCED PROSTATE CANCER
    February 22, 2006
    PALADIN REPORTS RECORD 2005 FOURTH QUARTER AND YEAR END RESULTS: COMPANY PROVIDES 2006 GUIDANCE
    (Also in PDF format)
    February 21, 2006
    PALADIN ANNOUNCES NORMAL COURSE ISSUER BID
    (Also in PDF format)
    February 9, 2006
    NOTICE OF PALADIN LAB'S FOURTH QUARTER AND 2005 YEAR-END RESULTS CONFERENCE CALL
    January 17, 2006
    NUVO SELLS ADDITIONAL CANADIAN PENNSAID'R' RIGHTS TO PALADIN SUBSIDIARY




    HOME | SITE MAP | LEGAL DISCLAIMER